That is very useful information, and explains why this preprint got so much traction here, I guess. I would have rather seen a post that's aimed at a more general audience, perhaps from the company blog or similar. It would have been able to provide the proper context to this audience, which is not an audience that is monitoring MedRXiv or has the skills to understand what this preprint means.